Cargando…

Body composition parameters correlate with the endoscopic severity in Crohn’s disease patients treated with infliximab

BACKGROUND: The disease activity status and behavior of Crohn’s disease (CD) can reflect the severity of the disease, and changes in body composition are common in CD patients. AIMS: The aim of this study was to investigate the relationship between body composition parameters and disease severity in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Wuli, Xie, Gang, Li, Junlin, Tan, Wei, Yi, Rongqi, Yang, Ling, Zhang, Lingqin, Deng, Jiaxing, Zhang, Yue, Li, Kang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Nutrition
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478258/ https://www.ncbi.nlm.nih.gov/pubmed/37674885 http://dx.doi.org/10.3389/fnut.2023.1251448

Ejemplares similares

Correlation Among Body Composition Parameters and Long-Term Outcomes in Crohn's Disease After Anti-TNF Therapy
por: Ando, Katsuyoshi, et al.
Publicado: (2022)

MRI-Based Radiomic Signature Identifying Secondary Loss of Response to Infliximab in Crohn's Disease
por: Feng, Jing, et al.
Publicado: (2022)

Influence of Vitamin D3 Supplementation on Infliximab Effectiveness in Chinese Patients With Crohn's Disease: A Retrospective Cohort Study
por: Xia, Sheng-long, et al.
Publicado: (2021)

Earlier anti-TNF therapy reduces the risk of malnutrition associated with alterations in body composition in patients with Crohn’s disease
por: Wang, Yuexin, et al.
Publicado: (2023)

Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease
por: Ma, Ye, et al.
Publicado: (2023)

Infliximab in the treatment of Crohn’s disease
por: Poggioli, Gilberto, et al.
Publicado: (2007)

Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn’s disease under infliximab therapy
por: Cao, Wan-Ting, et al.
Publicado: (2022)

Infliximab trough levels are associated with endoscopic healing but not with transmural healing at one year treatment with infliximab in pediatric patients with Crohn’s disease
por: Choi, So Yoon, et al.
Publicado: (2023)

Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease
por: Oh, Eun Hye, et al.
Publicado: (2017)

Effects of the probiotic Lactiplantibacillus plantarum IMC 510® on body composition, biochemical parameters, gut microbiota composition and function, and clinical symptoms of overweight/obese subjects
por: Pagliai, Giuditta, et al.
Publicado: (2023)

Infliximab to treat Crohn’s disease: an update
por: Cottone, M, et al.
Publicado: (2011)

Rapid assessment of malnutrition based on GLIM diagnosis in Crohn’s disease
por: Huang, Longchang, et al.
Publicado: (2023)

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
por: Vande Casteele, Niels, et al.
Publicado: (2015)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease
por: Gomes, Luis Eduardo Miani, et al.
Publicado: (2019)

The Effects of Polyphenol Supplementation in Addition to Calorie Restricted Diets and/or Physical Activity on Body Composition Parameters: A Systematic Review of Randomized Trials
por: Llaha, Fjorida, et al.
Publicado: (2020)

Computed tomography-based multiple body composition parameters predict outcomes in Crohn’s disease
por: Zhou, Ziling, et al.
Publicado: (2021)

Effect of Home Enteral Nutrition on Nutritional Status, Body Composition and Quality of Life in Patients With Malnourished Intestinal Failure
por: Gao, Xuejin, et al.
Publicado: (2021)

Correlations Between Iron Status and Body Composition in Patients With Type 2 Diabetes Mellitus
por: Zimiao, Chen, et al.
Publicado: (2022)

Responsiveness to an erythropoiesis-stimulating agent is correlated with body composition in patients undergoing chronic hemodialysis
por: Lee, Hyang Yun, et al.
Publicado: (2022)

Ramadan Fasting in Germany (17–18 h/Day): Effect on Cortisol and Brain-Derived Neurotrophic Factor in Association With Mood and Body Composition Parameters
por: Riat, Amin, et al.
Publicado: (2021)

Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis
por: Paiella, Salvatore, et al.
Publicado: (2023)

Profile of infliximab in the treatment of pediatric Crohn’s disease
por: Kierkus, Jaroslaw, et al.
Publicado: (2015)

Metastatic Crohn’s disease despite infliximab therapy
por: Campos, Sara, et al.
Publicado: (2017)

Myelolipoma After Infliximab Treatment for Crohn's Disease
por: Cesa, Kevin, et al.
Publicado: (2022)

Infliximab for medical induction of remission in Crohn's disease
por: Gordon, Morris, et al.
Publicado: (2023)

Henoch-Schönlein purpura associated with infliximab therapy for pediatric Crohn’s disease
por: Li, Xiaolu, et al.
Publicado: (2022)

Influence of previous corticosteroid treatment on the efficacy and safety of infliximab therapy in Crohn disease
por: Liu, Ailing, et al.
Publicado: (2019)

Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: a retrospective, multicenter analysis
por: Paiella, Salvatore, et al.
Publicado: (2023)

Body Composition in Swiss Elite Wheelchair Athletes
por: Flueck, Joelle Leonie
Publicado: (2020)

Infliximab‐induced seizures in a patient with Crohn’s disease: a case report
por: Lv, Zhijie, et al.
Publicado: (2021)

Editorial: Importance of body composition analysis in clinical nutrition
por: Bazzocchi, Alberto, et al.
Publicado: (2023)

The impact of medication belief on adherence to infliximab in patients with Crohn’s disease
por: Li, Shuyan, et al.
Publicado: (2023)

The impact of body composition and fat distribution on blood pressure in young and middle-aged adults
por: Zhao, Song, et al.
Publicado: (2022)

Optimized timing of using infliximab in perianal fistulizing Crohn's disease
por: Sun, Xue-Liang, et al.
Publicado: (2020)

Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn’s disease
por: Wang, Yizhong, et al.
Publicado: (2021)

Infliximab therapy in pediatric Crohn’s disease: a review
por: Parashette, Kalyan Ray, et al.
Publicado: (2010)

Maintenance treatment with infliximab for the management of Crohn’s disease in adults
por: Caviglia, Renato, et al.
Publicado: (2009)

Infliximab-induced intertriginous psoriasis in patient with Crohn's disease
por: Mola, Federica, et al.
Publicado: (2011)

Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
por: Kim, You Lim, et al.
Publicado: (2014)

Infliximab in the Treatment of Crohn Disease and Type 1 Diabetes
por: Timper, Katharina, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kk1cpihf1t2dvclgj6h96ts4dc